|
Effect of Transauricular Vagal Stimulation on Cardiac Function After Spinal Cord Injury
RECRUITINGN/ASponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Actively Recruiting
PhaseN/A
SponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
Started2024-03-20
Est. completion2025-07-16
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07007884
Summary
The aim of this study is to investigate the effect of transauricular vagal nerve stimulation (taVNS) on cardiac autonomic functions in patients with spinal cord injury (SCI).
Eligibility
Age: 18 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Aged between 18-60 2. Having a traumatic spinal cord injury 3. Cervical spinal cord injury patients with a history of autonomic dysreflexia 4. At least 6 months after the injury 5. Signing an informed consent form showing consent to participate in the study Exclusion Criteria: 1. Having a cardiac or neural pacemaker 2. Presence of pregnancy 3. Clinical coronary artery disease confirmed by invasive or coronary computed tomographic angiography 4. History of acute coronary syndrome (unstable angina, myocardial infarction) 5. Documented arrhythmia and/or use of antiarrhythmic drugs on ECG 6. Diagnosis of hypertension and use of antihypertensive drugs 7. Damaged skin lesion in the application area
Conditions2
Heart DiseaseSpinal Cord Injury (SCI)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
Started2024-03-20
Est. completion2025-07-16
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07007884